Overview
- WW International, formerly WeightWatchers, filed for Chapter 11 bankruptcy on May 6, aiming to eliminate $1.15 billion in debt while continuing operations.
- The company expects to complete the restructuring process in approximately 40–45 days, emerging as a publicly traded entity with support from its lenders and noteholders.
- WeightWatchers has struggled to compete with the rising popularity of GLP-1 weight-loss drugs, including Ozempic and Wegovy, which have disrupted its traditional business model.
- The 2023 acquisition of telehealth platform Sequence marked a strategic pivot toward prescribing weight-loss medications, with clinical subscription revenue increasing 57% year-over-year in Q1 2025.
- CEO Tara Comonte emphasized the company's commitment to innovation and member-focused solutions, ensuring no disruption to services during the reorganization.